Application 020885

Type
NDA
Sponsor
APOTEX TECHNOLOGIES

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PAXILPAROXETINE HYDROCHLORIDECAPSULE;ORALEQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002PAXILPAROXETINE HYDROCHLORIDECAPSULE;ORALEQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003PAXILPAROXETINE HYDROCHLORIDECAPSULE;ORALEQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004PAXILPAROXETINE HYDROCHLORIDECAPSULE;ORALEQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
41783SUPPL2011-12-09
41782SUPPL2011-12-09
21042SUPPL2011-12-09
23607ORIG2005-08-01
21041ORIG1998-10-09
3654ORIG1998-10-09